The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Gene Delivery Systems-Global Market Insights and Sales Trends 2024
Synopsis
Gene Delivery System or Gene therapy is an experimental technique that uses genes to treat or prevent disease. In the future, this technique may allow doctors to treat a disorder by inserting a gene into a patient's cells instead of using drugs or surgery.
The global Gene Delivery Systems market size is expected to reach US$ 9760.3 million by 2029, growing at a CAGR of 4.6% from 2023 to 2029. The market is mainly driven by the significant applications of Gene Delivery Systems in various end use industries. The expanding demands from the Infectious Diseases, Oncology, Ophthalmology and Urology, are propelling Gene Delivery Systems market. Viral Gene Delivery System, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Non-viral Gene Delivery System segment is estimated at % CAGR for the next seven-year period.
Gene Delivery System is widely used for Neurological Diseases, Cancer, etc. The Neurological Diseases occupied about 60% of market share, the cancer occupied about 35%.
North America is the largest consumption place, with a consumption market share nearly 62% in 2019. Following North America, Europe and Asia-Pacific occupied about 35% revenue market share in 2019.
Biogen, Novartis, Gilead Sciences, Sarepta Therapeutics, Alnylam Pharmaceuticals, Amgen,Spark Therapeutics, Akcea Therapeutics, bluebird bio, Sunway Biotech, SIBIONO, AnGes, Orchard Therapeutics, Human Stem Cells Institute and etc. are the leaders of the industry. In 2019,top 3 companies occupied over 80% of revenue market share.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Gene Delivery Systems, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Gene Delivery Systems market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Gene Delivery Systems market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Gene Delivery Systems sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Gene Delivery Systems covered in this report include Novartis, Amgen, Oxford BioMedica, SIBIONO, Shanghai Sunway Biotech, Roche, Pfizer, Bayer and Johnson & Johnson, etc.
The global Gene Delivery Systems market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Novartis
Amgen
Oxford BioMedica
SIBIONO
Shanghai Sunway Biotech
Roche
Pfizer
Bayer
Johnson & Johnson
Becton Dickinson
AstraZeneca
Baxter
HSCI
Epeius Biotechnologies
Global Gene Delivery Systems market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Gene Delivery Systems market, Segment by Type:
Viral Gene Delivery System
Non-viral Gene Delivery System
Combined Hybrid System
Global Gene Delivery Systems market, by Application
Infectious Diseases
Oncology
Ophthalmology
Urology
Diabetes
CNS
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Gene Delivery Systems companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Gene Delivery System or Gene therapy is an experimental technique that uses genes to treat or prevent disease. In the future, this technique may allow doctors to treat a disorder by inserting a gene into a patient's cells instead of using drugs or surgery.
The global Gene Delivery Systems market size is expected to reach US$ 9760.3 million by 2029, growing at a CAGR of 4.6% from 2023 to 2029. The market is mainly driven by the significant applications of Gene Delivery Systems in various end use industries. The expanding demands from the Infectious Diseases, Oncology, Ophthalmology and Urology, are propelling Gene Delivery Systems market. Viral Gene Delivery System, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Non-viral Gene Delivery System segment is estimated at % CAGR for the next seven-year period.
Gene Delivery System is widely used for Neurological Diseases, Cancer, etc. The Neurological Diseases occupied about 60% of market share, the cancer occupied about 35%.
North America is the largest consumption place, with a consumption market share nearly 62% in 2019. Following North America, Europe and Asia-Pacific occupied about 35% revenue market share in 2019.
Biogen, Novartis, Gilead Sciences, Sarepta Therapeutics, Alnylam Pharmaceuticals, Amgen,Spark Therapeutics, Akcea Therapeutics, bluebird bio, Sunway Biotech, SIBIONO, AnGes, Orchard Therapeutics, Human Stem Cells Institute and etc. are the leaders of the industry. In 2019,top 3 companies occupied over 80% of revenue market share.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Gene Delivery Systems, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Gene Delivery Systems market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Gene Delivery Systems market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Gene Delivery Systems sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Gene Delivery Systems covered in this report include Novartis, Amgen, Oxford BioMedica, SIBIONO, Shanghai Sunway Biotech, Roche, Pfizer, Bayer and Johnson & Johnson, etc.
The global Gene Delivery Systems market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Novartis
Amgen
Oxford BioMedica
SIBIONO
Shanghai Sunway Biotech
Roche
Pfizer
Bayer
Johnson & Johnson
Becton Dickinson
AstraZeneca
Baxter
HSCI
Epeius Biotechnologies
Global Gene Delivery Systems market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Gene Delivery Systems market, Segment by Type:
Viral Gene Delivery System
Non-viral Gene Delivery System
Combined Hybrid System
Global Gene Delivery Systems market, by Application
Infectious Diseases
Oncology
Ophthalmology
Urology
Diabetes
CNS
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Gene Delivery Systems companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Gene Delivery Systems
1.1 Gene Delivery Systems Market Overview
1.1.1 Gene Delivery Systems Product Scope
1.1.2 Gene Delivery Systems Market Status and Outlook
1.2 Global Gene Delivery Systems Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Gene Delivery Systems Market Size by Region (2018-2029)
1.4 Global Gene Delivery Systems Historic Market Size by Region (2018-2023)
1.5 Global Gene Delivery Systems Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Gene Delivery Systems Market Size (2018-2029)
1.6.1 North America Gene Delivery Systems Market Size (2018-2029)
1.6.2 Europe Gene Delivery Systems Market Size (2018-2029)
1.6.3 Asia-Pacific Gene Delivery Systems Market Size (2018-2029)
1.6.4 Latin America Gene Delivery Systems Market Size (2018-2029)
1.6.5 Middle East & Africa Gene Delivery Systems Market Size (2018-2029)
2 Gene Delivery Systems Market by Type
2.1 Introduction
2.1.1 Viral Gene Delivery System
2.1.2 Non-viral Gene Delivery System
2.1.3 Combined Hybrid System
2.2 Global Gene Delivery Systems Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Gene Delivery Systems Historic Market Size by Type (2018-2023)
2.2.2 Global Gene Delivery Systems Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Gene Delivery Systems Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Gene Delivery Systems Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Gene Delivery Systems Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Gene Delivery Systems Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Gene Delivery Systems Revenue Breakdown by Type (2018-2029)
3 Gene Delivery Systems Market Overview by Application
3.1 Introduction
3.1.1 Infectious Diseases
3.1.2 Oncology
3.1.3 Ophthalmology
3.1.4 Urology
3.1.5 Diabetes
3.1.6 CNS
3.1.7 Others
3.2 Global Gene Delivery Systems Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Gene Delivery Systems Historic Market Size by Application (2018-2023)
3.2.2 Global Gene Delivery Systems Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Gene Delivery Systems Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Gene Delivery Systems Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Gene Delivery Systems Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Gene Delivery Systems Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Gene Delivery Systems Revenue Breakdown by Application (2018-2029)
4 Gene Delivery Systems Competition Analysis by Players
4.1 Global Gene Delivery Systems Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Gene Delivery Systems as of 2022)
4.3 Date of Key Players Enter into Gene Delivery Systems Market
4.4 Global Top Players Gene Delivery Systems Headquarters and Area Served
4.5 Key Players Gene Delivery Systems Product Solution and Service
4.6 Competitive Status
4.6.1 Gene Delivery Systems Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Novartis
5.1.1 Novartis Profile
5.1.2 Novartis Main Business
5.1.3 Novartis Gene Delivery Systems Products, Services and Solutions
5.1.4 Novartis Gene Delivery Systems Revenue (US$ Million) & (2018-2023)
5.1.5 Novartis Recent Developments
5.2 Amgen
5.2.1 Amgen Profile
5.2.2 Amgen Main Business
5.2.3 Amgen Gene Delivery Systems Products, Services and Solutions
5.2.4 Amgen Gene Delivery Systems Revenue (US$ Million) & (2018-2023)
5.2.5 Amgen Recent Developments
5.3 Oxford BioMedica
5.3.1 Oxford BioMedica Profile
5.3.2 Oxford BioMedica Main Business
5.3.3 Oxford BioMedica Gene Delivery Systems Products, Services and Solutions
5.3.4 Oxford BioMedica Gene Delivery Systems Revenue (US$ Million) & (2018-2023)
5.3.5 SIBIONO Recent Developments
5.4 SIBIONO
5.4.1 SIBIONO Profile
5.4.2 SIBIONO Main Business
5.4.3 SIBIONO Gene Delivery Systems Products, Services and Solutions
5.4.4 SIBIONO Gene Delivery Systems Revenue (US$ Million) & (2018-2023)
5.4.5 SIBIONO Recent Developments
5.5 Shanghai Sunway Biotech
5.5.1 Shanghai Sunway Biotech Profile
5.5.2 Shanghai Sunway Biotech Main Business
5.5.3 Shanghai Sunway Biotech Gene Delivery Systems Products, Services and Solutions
5.5.4 Shanghai Sunway Biotech Gene Delivery Systems Revenue (US$ Million) & (2018-2023)
5.5.5 Shanghai Sunway Biotech Recent Developments
5.6 Roche
5.6.1 Roche Profile
5.6.2 Roche Main Business
5.6.3 Roche Gene Delivery Systems Products, Services and Solutions
5.6.4 Roche Gene Delivery Systems Revenue (US$ Million) & (2018-2023)
5.6.5 Roche Recent Developments
5.7 Pfizer
5.7.1 Pfizer Profile
5.7.2 Pfizer Main Business
5.7.3 Pfizer Gene Delivery Systems Products, Services and Solutions
5.7.4 Pfizer Gene Delivery Systems Revenue (US$ Million) & (2018-2023)
5.7.5 Pfizer Recent Developments
5.8 Bayer
5.8.1 Bayer Profile
5.8.2 Bayer Main Business
5.8.3 Bayer Gene Delivery Systems Products, Services and Solutions
5.8.4 Bayer Gene Delivery Systems Revenue (US$ Million) & (2018-2023)
5.8.5 Bayer Recent Developments
5.9 Johnson & Johnson
5.9.1 Johnson & Johnson Profile
5.9.2 Johnson & Johnson Main Business
5.9.3 Johnson & Johnson Gene Delivery Systems Products, Services and Solutions
5.9.4 Johnson & Johnson Gene Delivery Systems Revenue (US$ Million) & (2018-2023)
5.9.5 Johnson & Johnson Recent Developments
5.10 Becton Dickinson
5.10.1 Becton Dickinson Profile
5.10.2 Becton Dickinson Main Business
5.10.3 Becton Dickinson Gene Delivery Systems Products, Services and Solutions
5.10.4 Becton Dickinson Gene Delivery Systems Revenue (US$ Million) & (2018-2023)
5.10.5 Becton Dickinson Recent Developments
5.11 AstraZeneca
5.11.1 AstraZeneca Profile
5.11.2 AstraZeneca Main Business
5.11.3 AstraZeneca Gene Delivery Systems Products, Services and Solutions
5.11.4 AstraZeneca Gene Delivery Systems Revenue (US$ Million) & (2018-2023)
5.11.5 AstraZeneca Recent Developments
5.12 Baxter
5.12.1 Baxter Profile
5.12.2 Baxter Main Business
5.12.3 Baxter Gene Delivery Systems Products, Services and Solutions
5.12.4 Baxter Gene Delivery Systems Revenue (US$ Million) & (2018-2023)
5.12.5 Baxter Recent Developments
5.13 HSCI
5.13.1 HSCI Profile
5.13.2 HSCI Main Business
5.13.3 HSCI Gene Delivery Systems Products, Services and Solutions
5.13.4 HSCI Gene Delivery Systems Revenue (US$ Million) & (2018-2023)
5.13.5 HSCI Recent Developments
5.14 Epeius Biotechnologies
5.14.1 Epeius Biotechnologies Profile
5.14.2 Epeius Biotechnologies Main Business
5.14.3 Epeius Biotechnologies Gene Delivery Systems Products, Services and Solutions
5.14.4 Epeius Biotechnologies Gene Delivery Systems Revenue (US$ Million) & (2018-2023)
5.14.5 Epeius Biotechnologies Recent Developments
6 North America
6.1 North America Gene Delivery Systems Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Gene Delivery Systems Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Gene Delivery Systems Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Gene Delivery Systems Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Gene Delivery Systems Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Gene Delivery Systems Market Dynamics
11.1 Gene Delivery Systems Industry Trends
11.2 Gene Delivery Systems Market Drivers
11.3 Gene Delivery Systems Market Challenges
11.4 Gene Delivery Systems Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
